ArticleChemSusChem2025
Operando Investigation of Zr Doping in NMC811 Cathode for High Energy Density Lithium Ion Batteries.
Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Structure, Electrochemistry, and Phase Evolution of Al-Substituted NaChemistry of materials : a publication of the American Chemical Society · 2026Article
- Operando Investigation of Zr Doping in NMC811 Cathode for High Energy Density Lithium Ion Batteries.ChemSusChem · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
LiNi0.8Mn0.1Co0.1O2 (NMC811) is one of the most promising cathode materials for high energy density Li-ion batteries (LiBs). However, NMC811 suffers from capacity fading during electrochemical cycling because of its structure instability at voltages >4.2 V vs Li|Li
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.